LungLife AI, Inc.
LLAI.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | £46 | £24 | £196 | £205 |
| % Growth | 91.7% | -87.7% | -4.7% | – |
| Cost of Goods Sold | £0 | £0 | £96 | £188 |
| Gross Profit | £46 | £24 | £99 | £17 |
| % Margin | 100% | 100% | 50.8% | 8.3% |
| R&D Expenses | £1,308 | £1,981 | £1,343 | £647 |
| G&A Expenses | £1,337 | £6,865 | £1,930 | £3,796 |
| SG&A Expenses | £1,337 | £6,865 | £1,930 | £3,796 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £3,033 | -£1,184 | £2,170 | £283 |
| Operating Expenses | £5,678 | £7,662 | £5,443 | £4,079 |
| Operating Income | -£5,632 | -£7,638 | -£5,344 | -£4,062 |
| % Margin | -12,243.5% | -31,825% | -2,732.6% | -1,979.6% |
| Other Income/Exp. Net | £226 | £138 | -£199 | -£777 |
| Pre-Tax Income | -£5,406 | -£7,602 | -£7,428 | -£4,839 |
| Tax Expense | £7 | £4 | £16 | £777 |
| Net Income | -£5,413 | -£7,606 | -£7,444 | -£5,616 |
| % Margin | -11,767.4% | -31,691.7% | -3,806.5% | -2,737.2% |
| EPS | -0.21 | -0.3 | -0.47 | -0.22 |
| % Growth | 30% | 36.2% | -113.6% | – |
| EPS Diluted | -0.21 | -0.3 | -0.47 | -0.22 |
| Weighted Avg Shares Out | 25,486 | 25,481 | 15,870 | 25,481 |
| Weighted Avg Shares Out Dil | 25,486 | 25,481 | 15,870 | 25,481 |
| Supplemental Information | – | – | – | – |
| Interest Income | £223 | £88 | £12 | £0 |
| Interest Expense | £41 | £52 | £417 | £777 |
| Depreciation & Amortization | £254 | £285 | £323 | £283 |
| EBITDA | -£5,111 | -£7,265 | -£6,688 | -£3,779 |
| % Margin | -11,110.9% | -30,270.8% | -3,419.8% | -1,841.9% |